Lipid Drugs: Part 1
Guest: Alicia A. Mickow, APRN, C.N.P., M.S.N
Host: Stephen L. Kopecky, M.D.
In Part 1 of this two-part series, listeners will learn the challenges of managing patients who are statin-intolerant, the range of available treatment options, alternative dosing schedules, and strategies for introducing newer medications. Stay tuned for Part ... Show More
Sep 8
Cardioneural Ablation in Practice: Cases, Curves, and Clinical Impact
Cardioneural Ablation in Practice: Cases, Curves, and Clinical Impact Guest: Guru Kowlgi, M.B.B.S., M.S. Host: Anthony Kashou, M.D. In this episode of segment “ECG Making Waves” on Mayo Clinic podcast Interviews With the Experts, Dr. Anthony Kashou interviews Dr. Guru Kowlgi, a c ... Show More
16m 58s
Sep 1
Epidemiology of Myocarditis
Epidemiology of Myocarditis Guest: Leslie Cooper, M.D. Host: Sharonne Hayes, M.D. Approximately 1,000,000 cases of myocarditis are diagnosed annually with an incidence of approximately 16/100,000. The incidence is highest in men between 15 and 45 years of age. However, after age ... Show More
12m 36s
Jul 2022
REBOOT #191 Lipids and Cardiovascular Risk Reduction with Erin Michos MD
Lipids Update! Get up close and personal with ASCVD prevention and lipid management guidelines, including changes in the 2018 update, with our discussion with Dr. Erin Michos @erinmichos, preventive cardiologist and associate professor of medicine at the Johns Hopkins University ... Show More
1h 15m
Apr 2025
#174 Lp(a) and ASCVD Risk: 5 Pearls Segment
What does Lipoprotein(a) tell us that a standard lipid panel doesn’t? Should we be testing everyone for it? Dive into the genetics, clinical implications, and evolving management strategies for Lp(a). Learn how to interpret results, counsel patients, and navigate topics with limi ... Show More
43m 20s